skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 125  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: The Lancet remove subject: Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
Material Type:
Article
Add to My Research

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

The Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00018-6 ;PMID: 35085503

Full text available

2
12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial
Material Type:
Article
Add to My Research

12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial

The Lancet (British edition), 2007-03, Vol.369 (9567), p.1083-1089 [Peer Reviewed Journal]

Elsevier Ltd ;2007 Elsevier Ltd ;Copyright Elsevier Limited Mar 31-Apr 6, 2007 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(07)60526-1 ;PMID: 17398307 ;CODEN: LANCAO

Full text available

3
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Material Type:
Article
Add to My Research

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

The Lancet (British edition), 2024-03, Vol.403 (10432), p.1153-1163 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)02577-1 ;PMID: 38461843

Full text available

4
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
Material Type:
Article
Add to My Research

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

The Lancet (British edition), 2007-11, Vol.370 (9600), p.1687-1697 [Peer Reviewed Journal]

Elsevier Ltd ;2007 Elsevier Ltd ;Copyright Elsevier Limited Nov 17-Nov 23, 2007 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(07)61607-9 ;PMID: 17988728 ;CODEN: LANCAO

Full text available

5
Endothelial cell infection and endotheliitis in COVID-19
Material Type:
Article
Add to My Research

Endothelial cell infection and endotheliitis in COVID-19

The Lancet, 2020-05, Vol.395 (10234), p.1417-1418 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30937-5 ;PMID: 32325026

Digital Resources/Online E-Resources

6
Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial
Material Type:
Article
Add to My Research

Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial

The Lancet (British edition), 2011, Vol.377 (9762), p.301-311 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 22-Jan 28, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)62103-4 ;PMID: 21251705 ;CODEN: LANCAO

Full text available

7
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9699), p.1423-1431 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Oct 24-Oct 30, 2009 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61500-2 ;PMID: 19748665 ;CODEN: LANCAO

Full text available

8
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
Material Type:
Article
Add to My Research

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

The Lancet (British edition), 2016-09, Vol.388 (10050), p.1183-1192 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 17, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31339-3 ;PMID: 27542302 ;CODEN: LANCAO

Full text available

9
Heart failure
Material Type:
Article
Add to My Research

Heart failure

The Lancet (British edition), 2017-10, Vol.390 (10106), p.1981-1995 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 28, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31071-1 ;PMID: 28460827

Full text available

10
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
Material Type:
Article
Add to My Research

Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial

The Lancet (British edition), 2014-08, Vol.384 (9943), p.583-590 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 16, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61176-4 ;PMID: 25131977 ;CODEN: LANCAO

Full text available

11
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
Material Type:
Article
Add to My Research

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

The Lancet (British edition), 2013-01, Vol.381 (9860), p.29-39 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 5, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61855-8 ;PMID: 23141816 ;CODEN: LANCAO

Full text available

12
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Material Type:
Article
Add to My Research

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

The Lancet (British edition), 2017-06, Vol.389 (10085), p.2193-2203 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 3, 2017 ;2017. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)31193-5 ;PMID: 28494920

Full text available

13
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial
Material Type:
Article
Add to My Research

Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial

The Lancet (British edition), 2021-04, Vol.397 (10281), p.1293-1300 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00350-0 ;PMID: 33812488

Full text available

14
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial
Material Type:
Article
Add to My Research

Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

The Lancet (British edition), 2011-02, Vol.377 (9766), p.658-666 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 19-Feb 25, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60101-3 ;PMID: 21315441 ;CODEN: LANCAO

Full text available

15
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial
Material Type:
Article
Add to My Research

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

The Lancet (British edition), 2021-03, Vol.397 (10280), p.1195-1203 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00313-5 ;PMID: 33773631

Full text available

16
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
Material Type:
Article
Add to My Research

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

The Lancet (British edition), 2009-11, Vol.374 (9704), p.1840-1848 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2015 INIST-CNRS ;Copyright Elsevier Limited Nov 28-Dec 4, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61913-9 ;PMID: 19922995 ;CODEN: LANCAO

Full text available

17
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Material Type:
Article
Add to My Research

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

The Lancet (British edition), 2010-09, Vol.376 (9744), p.875-885 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 11-Sep 17, 2010 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61198-1 ;PMID: 20801500 ;CODEN: LANCAO

Full text available

18
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial
Material Type:
Article
Add to My Research

Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2022-03, Vol.399 (10328), p.945-955 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02225-X ;PMID: 35219377

Full text available

19
Post-radiation angiosarcoma of the breast in a patient with a history of invasive ductal carcinoma
Material Type:
Article
Add to My Research

Post-radiation angiosarcoma of the breast in a patient with a history of invasive ductal carcinoma

The Lancet (British edition), 2024-04, Vol.403 (10437), p.1681-1682 [Peer Reviewed Journal]

2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(24)00688-3 ;PMID: 38677859

Full text available

20
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study
Material Type:
Article
Add to My Research

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

The Lancet (British edition), 2004-05, Vol.363 (9423), p.1751-1756 [Peer Reviewed Journal]

2004 Elsevier Ltd ;2004 INIST-CNRS ;Copyright Lancet Ltd. May 29, 2004 ;Copyright Elsevier Limited May 29, 2004 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(04)16299-5 ;PMID: 15172772 ;CODEN: LANCAO

Full text available

Results 1 - 20 of 125  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait